
380.3K
Downloads
262
Episodes
The Cardiovascular CME podcast is a free educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes

Tuesday Aug 09, 2022
Chronic Thromboembolic Pulmonary Hypertension
Tuesday Aug 09, 2022
Tuesday Aug 09, 2022
Chronic Thromboembolic Pulmonary Hypertension
Guest: Vidhu Anand, MBBS, FACC, FASE (@vidhu_anand)
Host: Malcolm R. Bell, M.D.
Patients with Chronic Thromboembolic Pulmonary Hypertension have a life expectancy of one to three years if left untreated. CTPH is usually caused by blood clots that are prolonged in the body for a certain period. In addition, the blood tends to back up into the lungs, which increases the patient's blood pressure. Some risk factors that can lead to CTPH are obesity, smoking, and cancer.
Joining us today to discuss Chronic Thromboembolic Pulmonary Hypertension is Vidhu Anand, MBBS, FACC, FASE, assistant professor of medicine at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- What is chronic thromboembolic pulmonary hypertension?
- How is it diagnosed?
- What are different treatment options for management of CTEPH?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Thursday Aug 04, 2022
Manual Methods to Differentiate Wide Complex Tachycardias
Thursday Aug 04, 2022
Thursday Aug 04, 2022
Manual Methods to Differentiate Wide Complex Tachycardias
Guest: Adam M. May, M.D.
Hosts: Anthony H. Kashou, M.D. (@anthonykashoumd)
Joining us today to discuss Manual Methods to Differentiate Wide Complex Tachycardias is Adam M. May, M.D. cardiac intensivist, and assistant professor of medicine at Washington University School of Medicine in St. Louis, Missouri.
Specific topics discussed:
- Can you give us a broad overview of the different types of manual methods that clinicians have at their disposal to differentiate WCTs?
- You mentioned multi-step algorithms, which are commonly recognized and one of the utilized manual approaches. What do you think are the more common algorithms, and maybe you can share some of the overarching rationale behind their formulation?
- You made mention of VT AS A DEFAULT DIAGNOSIS. What do you mean by this and what is its rationale?
- How about some of the simple one-step methods such as the R-wave-to-peak time? Can you define this method, and share what you think about this method along with how you use it clinically?
- It appears that in many cases, VT and SWCT cannot be confidently distinguished using a single criterion alone and so many authors devise alternative approaches (like point-based algorithms). Can you go over the rationale for these methods and describe some of the options that might be helpful to use in clinical practice?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
Facebook: MayoCVservices
LinkedIn: Mayo Clinic Cardiovascular Services
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Aug 02, 2022
Peripheral Artery Disease (PAD) Treatment
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
Peripheral Artery Disease (PAD) Treatment
Guest: Robert D. McBane, II M.D.
Host: Stephen Kopecky, M.D. (@DrSteveKopecky)
Most patients, who have Peripheral Artery Disease, do not experience the symptoms right away. However, patients affected with PAD will likely experience symptoms such as pain in the legs during walking and loss of hair. PAD limits the blood flow from the vessels to the heart. Without the proper treatment, the effects of PAD can lead to amputation of the foot or legs. Major amputation can potentially lower the life expectancy of patients that are affected with PAD.
Joining us today to discuss Peripheral Artery Disease (PAD) Treatment is Robert D. McBane, II M.D. professor of medicine in the department of cardiovascular medicine at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- How do you define PAD?
- Is invasive or noninvasive imaging diagnosis required? Or can be based on ABI? Or is physical exam adequate with a bruit in the carotids, renals, or femorals?
- In PAD, are risk factors the same as in cardiovascular or cerebrovascular disease?
- Why is having PAD a greater risk factor for cardiovascular morbidity and mortality than coronary artery disease or cerebrovascular disease?
- Do any risk factors predominate in PAD? (e.g., is smoking more prevalent?)
- Are you checking lipoprotein a in patients with PAD at an early age?
- Has treatment of risk factors been shown to significantly reduce CV morbidity or mortality in patients with PAD?
- When is ABI indicated and when is toe-brachial index indicated? (What is the definition of noncompressible vessels?)
- When should we do exercise ABI?
- For treatment, other than treating the risk factors of lipids, smoking, hypertension, diabetes, or other treatments indicated such as anti-platelet and if so his aspirin adequate, what dose, or other anti-platelet agents indicated?
- Clopidogrel should be added when? Can be given in place of aspirin?
- When is cilostazol recommended? Can you give with heart failure-HFpEF and HFrEF? Does this improve outcomes-walking distance or also overall morbidity and mortality?
- What home walking program is best to recommend for patients with PAD?
- Do patients with PAD get as aggressive treatment for risk factor control as do CV or cerebrovascular disease patients?
- Why are patients with PAD less often treated aggressively for risk factor control? Is that the patient or the caregiver?
- Any other new drugs available that are beneficial?
- When is revascularization helpful to consider?
- There is emerging evidence that lower LDL cholesterol (LDL less than 60) significantly benefits patients with CAD-is there any evidence lower LDL is beneficial in PAD?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Jul 26, 2022
Aortic Regurgitation
Tuesday Jul 26, 2022
Tuesday Jul 26, 2022
Aortic Regurgitation
Guest: Vidhu Anand, MBBS, FACC, FASE (@vidhu_anand)
Host: Paul A Friedman, M.D. (@drpaulfriedman)
Joining us today to discuss Aortic Regurgitation is Vidhu Anand, MBBS, FACC, FASE, assistant professor of medicine at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- What is aortic regurgitation, how prevalent is it, and how are patients diagnosed and followed-up?
- Is there role of MRI in diagnosis and follow up of these patients?
- What are the different treatment options? Valve repair and replacement. We can discuss the very low operative mortality at centers of excellence, such as Mayo Clinic and option for valve repair which is particularly attractive for young patients who want to avoid anticoagulation
- Why is it important to refer patients early for intervention before there is onset of significant myocardial injury?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Thursday Jul 21, 2022
The ECG in Lyme Carditis
Thursday Jul 21, 2022
Thursday Jul 21, 2022
The ECG in Lyme Carditis
Guest: Adrian Baranchuk, M.D. (@adribaran)
Hosts: Anthony H. Kashou, M.D. (@anthonykashoumd)
Joining us today to discuss ECG in Lyme Carditis is Adrian Baranchuk, M.D., professor of medicine at Queen’s University in Kingston, Ontario, Canada.
Specific topics discussed:
- What is the role of the ECG in the diagnosis of Lyme carditis?
- Once suspected, what would you suggest doing to monitor heart rate?
- Any role for subsequent ECGs?
- If not treated, what could happen to a patient with first degree AV block?
- Do all patients with Lyme carditis need a pacemaker?
- How do you follow treated patients with Lyme carditis? What is the role of the ECG?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
Facebook: MayoCVservices
LinkedIn: Mayo Clinic Cardiovascular Services
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Jul 19, 2022
Echo in the OR
Tuesday Jul 19, 2022
Tuesday Jul 19, 2022
Echo in the OR
Guest: Hector Michelena, M.D. (@michelenahector)
Host: Kyle W. Klarich, M.D. (@KyleWKlarich)
Joining us today to discuss Echo in the OR is Hector Michelena, M.D., professor of medicine and research director for the division of structural heart disease and cardiovascular ultrasound at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- What is perioperative echo?
- What evidence supports intra-operative TEE?
- What are the crucial junctures during IOTEE and what are their principles?
- You said that valvular surgery was a critical aspect of IOTEE, what are the principles of IOTEE in valvular surgery?
- What didactic resources would you recommend for the echocardiographer learning IOTEE
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Jul 12, 2022
Why Quantitative Measures Matter in Valvular Heart Disease
Tuesday Jul 12, 2022
Tuesday Jul 12, 2022
Why Quantitative Measures Matter in Valvular Heart Disease
Guest: Jeremy J. Thaden, M.D. (@JeremyThaden)
Host: Kyle W. Klarich, M.D. (@KyleWKlarich)
Joining us today to discuss Why Quantitative Measures Matter in Valvular Heart Disease is Jeremy Thaden, M.D., assistant professor of cardiovascular medicine and vice chair for the division of cardiac ultrasound at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- How do you use valve quantification in echo and what are specific examples of quantitation in valvular heart disease?
- What is the benefit of quantifying valvular lesions?
- Where do you see echo quantitation going in the future?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Thursday Jul 07, 2022
ECG Features and Principles to Differentiate Wide Complex Tachycardias
Thursday Jul 07, 2022
Thursday Jul 07, 2022
ECG Features and Principles to Differentiate Wide Complex Tachycardias
Guest: Adam M. May, M.D.
Hosts: Anthony H. Kashou, M.D. (@anthonykashoumd)
Joining us today to discuss ECG Features and Principles to Differentiate Wide Complex Tachycardias is Adam M. May, M.D. cardiac intensivist, and assistant professor of medicine at Washington University School of Medicine in St. Louis, Missouri.
Specific topics discussed:
- What are some of the underlying electrophysiologic features you look for when trying to determine the site of origin of a wide complex tachyarrhythmia using the 12-lead ECG?
- You highlighted the importance of AV dissociation in distinguishing VT and SWCT. Can you discuss this concept in more detail, and how AV dissociation might manifest on the ECG?
- What do you mean by term morphologic criteria, and when is this helpful in differentiating WCTs?
- Another criterion we often look for is chest lead concordance. How exactly do you define this, and can you discuss the underlying electrophysiological basis for it as well as its practical value?
- Why is comparing a patient's WCT ECG and baseline ECG so valuable?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
Facebook: MayoCVservices
LinkedIn: Mayo Clinic Cardiovascular Services
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Jul 05, 2022
Inflammation and Heart Disease (CRP, ESR)
Tuesday Jul 05, 2022
Tuesday Jul 05, 2022
Inflammation and Heart Disease (CRP, ESR)
Guest: Anna Svatikova, M.D., Ph.D.
Host: Stephen Kopecky, M.D. (@DrSteveKopecky)
Joining us today to discuss Inflammation and Heart Disease is Anna Svatikova, M.D., Ph.D., assistant professor of medicine in the department of cardiovascular diseases, a division of preventive cardiology at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- What is inflammation as it relates to the heart and CV system?
- What are the effects of inflammation? Are there symptoms? If so, what are they?
- Is it important and if so, why?
- What causes inflammation? Lifestyle? Weight? Food? Physical activity?
- How can someone reduce inflammation in their body? Medications? Lifestyle? Foods? Physical activity?
- How do we measure inflammation? Are there blood tests or physical exam findings?
- How does the body react to inflammation – is the bone marrow involved?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Tuesday Jun 28, 2022
Tuesday Jun 28, 2022
FH: What it is, Increased Cardiovascular Risk, Ruling Out Secondary Causes, and When to Refer
Guest: Alicia Mickow, APRN, C.N.P., M.S.N. (@aliann2011)
Host: Stephen Kopecky, M.D. (@DrSteveKopecky)
Joining us today to discuss Familial Hypercholesterolemia is Alicia Mickow, APRN, C.N.P., M.S.N., nurse practitioner at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- What is FH? What is the clinical definition?
- What causes FH? Polygenic vs monogenic
- How do we categorize FH?
- Clinical criteria,
- LDL Criteria ≥190 mg,
- Genetic criteria
- What is the Overlap Among the Different Definitions of Familial Hypercholesterolemia?
- When should we suspect FH?
- Is treatment different than what we give patients that do not have Familial Hypercholesterolemia?
- What is the goal of therapy FH?
- Are all patients with high LDL at risk for developing CAD?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
NEW Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.